CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,824,984 | +1408.2% | 434,024 | +1131.7% | 0.06% | +1350.0% |
| Q2 2023 | $784,023 | -43.8% | 35,237 | -45.3% | 0.00% | -42.9% |
| Q1 2023 | $1,394,471 | +3.5% | 64,380 | -2.9% | 0.01% | -12.5% |
| Q4 2022 | $1,347,183 | -78.3% | 66,331 | -72.6% | 0.01% | -75.8% |
| Q3 2022 | $6,204,000 | -16.6% | 241,973 | -22.7% | 0.03% | -13.2% |
| Q2 2022 | $7,439,000 | -14.5% | 312,843 | -19.0% | 0.04% | -22.4% |
| Q1 2022 | $8,698,000 | +547.7% | 386,249 | +469.5% | 0.05% | +600.0% |
| Q4 2021 | $1,343,000 | -12.2% | 67,824 | +5.5% | 0.01% | -36.4% |
| Q1 2021 | $1,529,000 | -75.0% | 64,270 | -72.5% | 0.01% | -78.4% |
| Q4 2020 | $6,106,000 | -0.6% | 233,405 | -33.9% | 0.05% | 0.0% |
| Q3 2020 | $6,142,000 | +158.1% | 352,903 | +149.4% | 0.05% | +88.9% |
| Q2 2020 | $2,380,000 | +61.0% | 141,518 | +13.8% | 0.03% | -35.7% |
| Q1 2020 | $1,478,000 | -11.0% | 124,321 | -9.4% | 0.04% | +31.2% |
| Q4 2019 | $1,660,000 | +226.8% | 137,224 | +281.8% | 0.03% | +255.6% |
| Q3 2019 | $508,000 | – | 35,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |